Psychostimulants and schizophrenic relapse
Weiss, K.J.
Journal of Clinical Psychiatry 47(1): 48
1986
ISSN/ISBN: 0160-6689 PMID: 3941062 Document Number: 274559
Document emailed within 1 workday
Related Documents
Kinon, B.J.; Kane, J.M.; Johns, C.; Perovich, R.; Ismi, M.; Koreen, A.; Weiden, P. 1993: Treatment of neuroleptic-resistant schizophrenic relapse Psychopharmacology Bulletin 29(2): 309-314Irle, G.; Pörksen, N. 1971: Social integration of schizophrenic patients with and without relapse from their own viewpoint. I Der Nervenarzt 42(9): 466-475
Jenkins, J.H.; Karno, M.; de la Selva, A.; Santana, F.; Telles, C.; Lopez, S.; Mintz, J. 1986: Expressed emotion, maintenance pharmacotherapy, and schizophrenic relapse among Mexican-Americans Psychopharmacology Bulletin 22(3): 621-627
Dienstbier, Z.; Hermanská, Z.; Zámecník, J.; Melínová, L.; Vacková, B.; Skala, E.; Srbová, D. 1995: Relapse in Hodgkin's disease. Incidence of relapse in a group of 374 patients from 1 June 1968 to 31 March 1995 Vnitrni Lekarstvi 41(12): 816-821
Schmid, H.; von Schenck, U.; Hartmann, R.; Borgmann, A.; Henze, G. 1996: Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: results of BFM ALL relapse studies. BFM Relapse Study Group Bone Marrow Transplantation 18(Suppl 2): 28-30
Kirkpatrick, R.D. 1991: Psychostimulants and Tennessee law American Family Physician 44(2): 398
Yamada, K.; Kawasumi, Y.; Yasuda, A.; Seki, Y.; Adachi, T.; Tarumi, O.; Hayashi, Y.; Nakagawa, T.; Yamada, N.; Ogawa, K. 2016: Changes in Mac Antibody Levels before and after Surgery and at the time of Relapse/Recurrence in Mac Lung Disease--Can Mac Antibodies be an Indicator of Postoperative Relapse/Recurrence? Kekkaku: 91(2): 41-44
Kochman, F.éd.ér.; Karila, L.; Tiravi, S. 2002: Role of psychostimulants in hyperactive children La Revue du Praticien 52(18): 2017-2022
Nanikawa, R.; Kotoku, S.; Sumida, Y. 1970: Separation and identification of tranquilizers and psychostimulants by means of gas chromatography Nihon Hoigaku Zasshi 24(4): 326-330
Kohl, R.L.; Lewis, M.R. 1987: Mechanisms underlying the antimotion sickness effects of psychostimulants Aviation Space and Environmental Medicine 58(12): 1215-1218
Herz, A. 1995: Neurobiological principles of drug dependence. Exemplified by opioids and psychostimulants Der Nervenarzt 66(1): 3-14
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41
Baturin, V.A. 1976: Effect of psychostimulants on the relearning by rats of the avoidance direction in a U-shaped labyrinth Biulleten' Eksperimental'noi Biologii i Meditsiny 81(5): 554-556
Protiva, M. 1971: Advances in the chemistry of psychotropic drugs in 1970. I. Psychoamimetics, psychostimulants, thymoleptics Ceskoslovenska Farmacie 20(9): 349-356
Kostowski, W.; Jerlicz, M.; Bidziński, A.; Hauptmann, M. 1978: Behavioral effects of some neuroleptics and psychostimulants in rats with bilateral lesions of the locus coeruleus Polish Journal of Pharmacology and Pharmacy 30(2-3): 305-306
Ben'kovich, B.I. 1991: The clinico-pharmacological analysis of the neurotropic action of psychostimulants and preparations with a metabolic type of action Farmakologiia i Toksikologiia 54(6): 66-69
Rodríguez Arenas, M.A.; Barrio Anta, G.; de la Fuente de Hoz, L.; Royuela, L. 1997: Emergencies associated with the consumption of designer drugs, hallucinogens and amphetamines treated at 15 Spanish hospitals in 1994. Work Group on the Study of Emergencies due to Psychostimulants Revista Clinica Espanola 197(12): 804-809
Markus, M.B. 1980: Relapse in malaria South African Medical Journal 57(10): 344
Rajan, M.A. 1995: Relapse after MDT in MB cases Indian Journal of Leprosy 67(1): 103-105
Bourgoin, G. 1985: The relapse in orthodontics. A discussion L' Orthodontie Francaise 56(2): 319-346